Cheaper Weight-Loss Drugs In India: A Big Shift In Fight Against ‘Diabesity’

With patent expiry opening doors for affordable medicines, experts say access will improve but caution against misuse

India is entering a major turning point in the treatment of diabetes and obesity, often referred to together as ‘diabesity’. The expiry of a key drug patent has paved the way for cheaper weight-loss and diabetes medicines, potentially transforming how millions manage these conditions.

What Has Changed

A crucial patent for semaglutide, a widely used molecule for diabetes and weight loss has expired, allowing Indian pharmaceutical companies to launch more affordable generic versions. This is expected to significantly reduce treatment costs and expand access.

Why This Matters For India

India faces a massive burden of metabolic diseases. Millions of people are living with diabetes, prediabetes, and obesity, making treatment affordability a critical concern. Until now, advanced therapies remained out of reach for many due to high costs.

Prices Expected To Drop Sharply

The entry of multiple generic versions is likely to bring prices down by 50–60%. Monthly treatment costs, which were earlier very high, could drop to a fraction, making these medicines accessible to a much wider population.

Surge Of New Options In Market

Over 40 pharmaceutical companies are expected to introduce multiple versions of these drugs. While this will improve availability, it may also create confusion among patients due to the large number of brands entering the market at once.

Why These Drugs Are Called Game-Changers

GLP-1 based medicines like semaglutide help control blood sugar levels and also support significant weight loss. They have shown results that earlier treatments struggled to achieve, making them highly effective for long-term management.

Concerns Around Misuse

Experts have raised concerns that easier access may lead to misuse, especially for cosmetic or lifestyle weight loss without proper medical supervision. There is also a risk of people purchasing these drugs directly without prescriptions.

Doctors Urge Caution

Medical professionals emphasise that these treatments are not a quick fix. Proper diagnosis, dosage, and monitoring are essential. Choosing a drug should depend on medical advice, not just affordability.

What Will Decide Market Success

Even with lower prices, doctors’ trust and confidence in specific brands will play a key role. Over time, only a few reliable brands are expected to dominate based on quality, consistency, and outcomes.

The Bottom Line

Cheaper weight-loss drugs could make advanced treatment accessible to millions in India, but responsible use and medical guidance will be critical to ensure long-term benefits.

Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before starting any medication.